If you have lost money in the stock market due to fraud, misrepresentation, negligence, or for other reasons, we can help you. We have successfully recovered over $250 million in FINRA securities arbitrations.*
Need Legal Help? Contact Us. Call +1 (888) 997-9956
New York (Globe Newswire) – June 8, 2016 – The Securities Arbitration Law Firm of KlaymanToskes, www.klaymantoskes.com, announced today that it has commenced a comprehensive investigation into Oppenheimer’s (NYSE:OPY) sales practices regarding inverse and inverse-leveraged ETFs that were unsuitable for clients in light of the $3 million fine levied against Oppenheimer by FINRA.
According to securities attorney Lawrence Klayman, “the scope of our investigation is related to leveraged, inverse and inverse-leveraged ETFs which Oppenheimer sold to clients despite investment objectives and risk tolerances that should have prohibited such investments from being made. Additionally, Mr. Klayman explains, “Oppenheimer lacked the requisite supervision to safeguard unsophisticated, risk averse investors from buying these risky ETFs.”
KlaymanToskes is investigating Oppenheimer’s conduct with respect to unsuitable recommendations, misrepresentations and omissions, and failure to supervise. The investigation is focused on the adequacy of Oppenheimer’s supervisory system for the non-traditional ETFs and the manner in which Oppenheimer’s representatives solicited investors to purchase these unsuitable investments.
The sole purpose of this release is to investigate the sales practices of Oppenheimer in connection with the sale of non-traditional ETFs to their customers. Current and former customers of Oppenheimer who purchased non-traditional ETFs that have information relating to the manner in which the firm represented these products, are encouraged to contact Lawrence Klayman, Esq. or Raymond Gentile, Esq. of KlaymanToskes at (888) 997-9956, or visit our website at www.klaymantoskes.com.